Editorial: The AIDS crisis, cost-effectiveness and academic activism.
Boelaert
Marleen
M
Van Damme
Wim
W
Meessen
Bruno
B
Van der Stuyft
Patrick
P
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000517:prevention & control; D017954:Africa South of the Sahara; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D017048:Health Care Costs; D006801:Humans; D007391:International Cooperation